Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  SHANGHAI STOCK EXCHANGE  >  Shanghai Fosun Pharmaceutical Group    600196   CNE000000X38

SHANGHAI FOSUN PHARMACEUTICAL GROUP

(600196)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsAnalyst Recommendations

Shanghai Fosun Pharmaceutical : MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 SEPTEMBER 2019 (H SHARES)

share with twitter share with LinkedIn share with facebook
share via e-mail
0
10/08/2019 | 05:30am EST

Monthly Return of Equity Issuer on Movements in Securities

For the month ended

(dd/mm/yyyy) :30/09/2019

To : Hong Kong Exchanges and Clearing Limited

Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

Name of Issuer

(a joint stock limited company incorporated in the People's Republic of China with

limited liability)

Date Submitted

08/10/2019

I. Movements in Authorised Share Capital

1. Ordinary Shares

(1) Stock code :

02196

Description :

H Shares

No. of ordinary

Authorised share

Par value

capital

shares

(RMB)

(RMB)

Balance at close of preceding month

(See Remark 1)

(See Remark 1)

Increase/(decrease)

(See Remark 1)

(See Remark 1)

Balance at close of the month

(See Remark 1)

(See Remark 1)

(2) Stock code :

N/A

Description :

A Shares (Domestic Shares)

No. of ordinary

Authorised share

Par value

capital

shares

(RMB)

(RMB)

Balance at close of preceding month

(See Remark 1)

(See Remark 1)

Increase/(decrease)

(See Remark 1)

(See Remark 1)

Balance at close of the month

(See Remark 1)

(See Remark 1)

2. Preference Shares

Stock code :

N/A

Description :

N/A

No. of

Par value

Authorised share

preference

(State

capital

shares

currency)

(State currency)

Balance at close of preceding month

Increase/(decrease)

Balance at close of the month

3. Other Classes of Shares

Stock code :

N/A

Description :

N/A

No. of other

Par value

Authorised share

classes of

(State

capital

shares

currency)

(State currency)

Balance at close of preceding month

Increase/(decrease)

Balance at close of the month

Total authorised share capital at the end of the month (State

currency) :

(See Remark 1)

II. Movements in Issued Share Capital

No. of ordinary shares

No of preference

No. of other

(1)

(2)

H Shares

A Shares

shares

classes of shares

Balance at close of

preceding month

551,940,500

2,010,958,045

N/A

N/A

Increase/ (decrease)

during the month

NIL

NIL

N/A

N/A

Balance at close of

the month

551,940,500

2,010,958,045

N/A

N/A

III. Details of Movements in Issued Share Capital

Share Options (under Share Option Schemes of the Issuer)

Particulars of

No. of new shares of

No. of new shares of

share option

issuer issued during

issuer which may be

scheme

the month pursuant

issued pursuant

including EGM

Movement during the month

thereto

thereto as at close of

approval date

the month

(dd/mm/yyyy) and

class of shares

issuable

Granted

Exercised

Cancelled

Lapsed

1. N/A

(

/

/

)

shares

(Note 1)

2. N/A

(

/

/

)

shares

(Note 1)

3. N/A

(

/

/

)

shares

(Note 1)

Total A. (Ordinary shares) N/A (Preference shares) N/A (Other class) N/A

Total funds raised during the month from exercise

of options (State currency)

N/A

Warrants to Issue Shares of the Issuer which are to be Listed

No. of new

No. of new

shares of

shares of

issuer

issuer which

issued

may be

during the

issued

Nominal value

month

pursuant

Currency

at close of

Exercised

Nominal value

pursuant

thereto as at

Description of warrants

of nominal

preceding

during the

at close of the

thereto

close of the

(Date of expiry - dd/mm/yyyy)

value

month

month

month

month

1. N/A

(

/ /

)

Stock code (if listed)

Class of shares

issuable (Note 1)

Subscription price

EGM approval date

(if applicable)

(dd/mm/yyyy)

( / /

)

2. N/A

(

/ /

)

Stock code (if listed)

Class of shares

issuable (Note 1)

Subscription price

EGM approval date

(if applicable)

(dd/mm/yyyy)

( / /

)

3. N/A

(

/ /

)

Stock code (if listed)

Class of shares

issuable (Note 1)

Subscription price

EGM approval date

(if applicable)

(dd/mm/yyyy)

( / /

)

4. N/A

(

/ /

)

Stock code (if listed)

Class of shares

issuable (Note 1)

Subscription price

EGM approval date

(if applicable)

(dd/mm/yyyy)

( / /

)

Total B. (Ordinary shares) N/A (Preference shares) N/A (Other class) N/A

Convertibles (i.e. Convertible into Shares of the Issuer which are to be Listed)

No. of new

No. of new

shares of

shares of

issuer

issuer which

issued

may be

during the

issued

month

pursuant

Amount at

pursuant

thereto as at

Currency of

close of

Converted

Amount at

thereto

close of the

amount

preceding

during the

close of the

month

Class and description

outstanding

month

month

month

1. N/A

Stock code (if listed)

Class of shares

issuable (Note 1)

Subscription price

EGM approval date

(if applicable)

(dd/mm/yyyy))

( / /

)

2. N/A

Stock code (if listed)

Class of shares

issuable (Note 1)

Subscription price

EGM approval date

(if applicable)

(dd/mm/yyyy)

( / /

)

3. N/A

Stock code (if listed)

Class of shares

issuable (Note 1)

Subscription price

EGM approval date

(if applicable)

(dd/mm/yyyy)

( / /

)

4. N/A

Stock code (if listed)

Class of shares

issuable (Note 1)

Subscription price

EGM approval date

(if applicable)

(dd/mm/yyyy)

( / /

)

Total C. (Ordinary shares) N/A (Preference shares) N/A (Other class) N/A

This is an excerpt of the original content. To continue reading it, access the original document here.

Disclaimer

Shanghai Fosun Pharmaceutical (Group) Co. Ltd. published this content on 08 October 2019 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 08 October 2019 09:29:06 UTC

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on SHANGHAI FOSUN PHARMACEUTI
11/01SHANGHAI FOSUN PHARMACEUTICAL : Inside information - proposed overseas listing o..
PU
11/01SHANGHAI FOSUN PHARMACEUTICAL : Connected transaction - entering into the capita..
PU
11/01SHANGHAI FOSUN PHARMACEUTICAL : Inside information - proposed overseas listing o..
PU
11/01SHANGHAI FOSUN PHARMACEUTICAL : Connected transaction - entering into the capita..
PU
10/29SHANGHAI FOSUN PHARMACEUTICAL : 2019 third quarterly report(h shareᦀ..
PU
10/21SHANGHAI FOSUN PHARMACEUTICAL : Poll results of the resolution proposed at the 2..
PU
10/15SHANGHAI FOSUN PHARMACEUTICAL : Announcement - on completion of the issuance of ..
PU
10/08SHANGHAI FOSUN PHARMACEUTICAL : Monthly return of equity issuer on movements in ..
PU
08/26SHANGHAI FOSUN PHARMACEUTICAL GROUP : Half-year results
CO
08/02SHANGHAI FOSUN PHARMACEUTICAL GROUP : Ex-dividend day for final dividend
FA
More news
Financials (CNY)
Sales 2019 28 978 M
EBIT 2019 2 664 M
Net income 2019 3 312 M
Debt 2019 16 439 M
Yield 2019 1,49%
P/E ratio 2019 20,6x
P/E ratio 2020 18,3x
EV / Sales2019 2,84x
EV / Sales2020 2,40x
Capitalization 65 805 M
Chart SHANGHAI FOSUN PHARMACEUTICAL GROUP
Duration : Period :
Shanghai Fosun Pharmaceutical Group Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SHANGHAI FOSUN PHARMACEUTI
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 11
Average target price 31,64  CNY
Last Close Price 26,90  CNY
Spread / Highest target 37,5%
Spread / Average Target 17,6%
Spread / Lowest Target -18,6%
EPS Revisions
Managers
NameTitle
Yi Fang Wu President, CEO & Executive Director
Qi Yu Chen Co-Chairman
Fang Yao Co-Chairman
Qian Ren Chairman-Supervisory Board
Xiao Hui Guan CFO, Chief Accountant Officer & Senior VP
Sector and Competitors